| Filed On | Filing |
|---|---|
| 15 Oct 2026 |
Form 4: Larosa Steven P, Chief Medical Officer
Received 42,000 shares as a grant or award |
| 15 Oct 2026 |
Form 4: Shah Chetan, Director
Gave up 436 shares to cover exercise price or tax ($2.84K) |
| 15 Oct 2026 |
Form 4/A: Rossetti Angela, Director
Received 21,815 shares as a grant or award ($50K) |
| 15 Oct 2026 |
Form 4: Gikakis Nicolas, Director
Gave up 436 shares to cover exercise price or tax ($2.84K) |
| 15 Oct 2026 |
Form 4: Broenniman Edward G, Director
Gave up 218 shares to cover exercise price or tax ($1.42K) |
| 13 Oct 2026 |
Form 4: Frakes James B, Director
Received 42,000 shares as a grant or award |
| 13 Oct 2026 | SCHEDULE 13G |
| 09 Oct 2026 |
8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Record Nurrnber Fllecl In the Office af C3159 - 1991 f'Jlff ೦ FlUng - Numberrrom: 1v1arr. 1 - 111 F202610081657 FUecl Oil Secretary of State State Of Nevada 10/0812026 12•53 PM Number of Pages 2 r - ·· - 12: - :fo:ss i:i.m.10 ೦ 01 - 2020... |
| 05 Oct 2026 |
8-K/A: Submission of Matters to a Vote of Security Holders
Proposal No. 7: The Company’s stockholders did not approve a proposed amendment to the Company's Articles of Incorporation to authorize 20,000,000 shares of preferred stock, par value $0.001 per share, and authorize the Board of Director... |
| 01 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders
(a) Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; (ii) the Prior Plan’s Available Res... |
| 17 Sep 2026 | FORM 8-K |
| 17 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Changes in Control of Registrant +1 more
First Certificate of Merger, including certificate of incorporation of the First Step Surviving Corporation attached as Exhibit A thereto, incorporated by reference into this Agreement |
| 15 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This Amendment No. 2 to Executive Employment Agreement (this “Amendment”) is made and entered into as of September 11, 2026 (the “Amendment Effective Date”), by and between James B. Frakes (“Employee”) and Aethlon Medical, Inc., a Nevada... |
| 04 Sep 2026 | FORM DEFA14A |
| 01 Sep 2026 |
Proxy statement: annual meeting on October 1, 2026
CEO pay $827K, up 65% · say-on-pay vote |
| 31 Aug 2026 | 8-K: Other Events |
| 21 Aug 2026 | PRELIMINARY PROXY STATEMENT |
| 13 Aug 2026 | FORM 10-Q FOR JUN 2026 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
Loading...